Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1/3, 612 42 Brno, Czech Republic.
Bioorg Med Chem. 2012 Jan 1;20(1):86-95. doi: 10.1016/j.bmc.2011.11.033. Epub 2011 Nov 28.
Skin penetration enhancers are compounds used to facilitate the transdermal delivery of drugs that are otherwise not sufficiently permeable. Through a synthetic route implementing two series of esters, we generated transdermal penetration enhancers by a multi-step reaction with substituted 6-aminohexanoic acid. We present the synthesis of all newly prepared compounds here with structural confirmation accomplished by (1)H NMR, (13)C NMR, IR and mass spectroscopy (MS). The lipophilicity (logk) of all compounds was determined via RP-HPLC and their hydrophobicity (logP/ClogP) was also calculated using two commercially available programs. Ab initio calculations of geometry and molecular dynamic simulations were employed to investigate the 3-dimensional structures of selected compounds. The transdermal penetration-enhancing activity of all the synthesized esters were examined in vitro and demonstrated higher enhancement ratios than oleic acid. Compounds 2e (C(10) ester chain) and 2f (C(11) ester chain) exhibited the highest enhancement ratios. It can be concluded that the series non-substituted at the C((2)) position by a ω-lactam ring showed significantly higher activity than those with azepan-2-one. None of the prepared compounds penetrated through the skin. All of the investigated agents demonstrated minimal anti-proliferative activity using the SK-N-MC neuroepithelioma cell line (IC(50)>6.25μM), suggesting these analogs would have a low cytotoxic profile when administered in vivo as chemical penetration enhancers. The correlation between the chemical structure of the studied compounds and their lipophilicity is discussed in regards to transdermal penetration-enhancing activity.
皮肤渗透增强剂是用于促进药物经皮递送的化合物,这些药物否则不能充分渗透。通过采用两种酯系列的合成路线,我们使用取代的 6-氨基己酸通过多步反应生成了经皮渗透增强剂。我们在这里介绍了所有新制备的化合物的合成,通过 (1)H NMR、(13)C NMR、IR 和质谱 (MS) 完成了结构确证。所有化合物的亲脂性 (logk) 通过反相高效液相色谱法 (RP-HPLC) 确定,其疏水性 (logP/ClogP) 也使用两个商业上可用的程序进行了计算。使用从头算计算几何和分子动力学模拟来研究选定化合物的 3 维结构。所有合成酯的经皮渗透增强活性均在体外进行了检查,并表现出比油酸更高的增强比。化合物 2e(C(10)酯链)和 2f(C(11)酯链)表现出最高的增强比。可以得出结论,与具有氮杂环庚烷-2-酮的化合物相比,在 C((2)) 位置未被ω-内酰胺环取代的系列化合物显示出明显更高的活性。没有一种制备的化合物能够穿透皮肤。所有研究的试剂在 SK-N-MC 神经上皮细胞瘤系中均表现出最小的抗增殖活性(IC(50)>6.25μM),这表明这些类似物在体内作为化学渗透增强剂给药时具有低细胞毒性特征。讨论了研究化合物的化学结构与其亲脂性之间的相关性,以探讨其经皮渗透增强活性。